SNES icon

SenesTech

2.93 USD
-0.08
2.66%
At close Dec 20, 4:00 PM EST
After hours
2.65
-0.28
9.56%
1 day
-2.66%
5 days
-27.83%
1 month
31.98%
3 months
17.20%
6 months
-51.57%
Year to date
-81.69%
1 year
-55.61%
5 years
-99.98%
10 years
-100.00%
 

About: SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

Employees: 25

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

74% more capital invested

Capital invested by funds: $85.1K [Q2] → $148K (+$63K) [Q3]

8.18% more ownership

Funds ownership: 2.86% [Q2] → 11.04% (+8.18%) [Q3]

56% less funds holding

Funds holding: 9 [Q2] → 4 (-5) [Q3]

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$10
241%
upside
Avg. target
$10
241%
upside
High target
$10
241%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Amit Dayal
39% 1-year accuracy
44 / 112 met price target
241%upside
$10
Buy
Reiterated
13 Dec 2024

Financial journalist opinion

Neutral
Seeking Alpha
1 month ago
SenesTech, Inc. (SNES) Q3 2024 Earnings Call Transcript
SenesTech, Inc. (NASDAQ:SNES ) Q3 2024 Earnings Conference Call November 12, 2024 5:00 PM ET Company Participants Robert Blum - Lytham Partners Joel Fruendt - Chief Executive Officer Tom Chesterman - Chief Financial Officer Operator Good day and welcome to the SenesTech Third Quarter Fiscal Year 2024 Financial Results Conference Call. All participants will be in a listen-only mode for the duration of the call.
SenesTech, Inc. (SNES) Q3 2024 Earnings Call Transcript
Neutral
PRNewsWire
1 month ago
SenesTech Announces Third Quarter 2024 Financial Results
Record Revenue and Margin Performance PHOENIX , Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercial and consumer available EPA-registered Rat Birth Control® products today announced financial results for the third quarter of 2024. Recent Highlights Revenues of $1.4 million in the first nine months of 2024, an increase of 51% compared to the same period of 2023.
SenesTech Announces Third Quarter 2024 Financial Results
Neutral
PRNewsWire
1 month ago
SenesTech Launches Evolve™ Rodent Birth Control on Walmart Marketplace
Significantly Expanding Market Reach PHOENIX , Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), a leader in fertility control solutions for managing animal pest populations, is excited to announce a significant expansion in the distribution of its groundbreaking rodent birth control product. Evolve™ Rat and Evolve™ Mouse are now available on Walmart Marketplace, one of the largest and most trusted eCommerce platforms in the world.
SenesTech Launches Evolve™ Rodent Birth Control on Walmart Marketplace
Neutral
PRNewsWire
1 month ago
SenesTech to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , Nov. 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on Tuesday, November 12, 2024. The Company has scheduled a conference call that same day, Tuesday, November 12, 2024, at 5:00 pm ET, to review the results.
SenesTech to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
Neutral
PRNewsWire
1 month ago
Evolve™ Registered in Hong Kong; Offering a Revolutionary Non-Lethal Rodent Control Solution
PHOENIX , Oct. 31, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), the leader in birth control to manage rodent pest populations, today announces the successful registration of Evolve™ in Hong Kong. A Sustainable and Humane Approach to Rodent Control Hong Kong welcomes Evolve™, an innovative, non-lethal rodent birth control solution designed to target rat infestations at their root.
Evolve™ Registered in Hong Kong; Offering a Revolutionary Non-Lethal Rodent Control Solution
Neutral
PRNewsWire
2 months ago
New York City to Pursue Rat Contraception Pilot Program
PHOENIX , Oct. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), the leader in birth control to manage rodent pest populations, today announces that the New York City Council has approved a bill to implement a rat contraception pilot program. From the bill, the term "rat contraceptive" means an agent for the reduction of reproductive capacity in rats that is approved for such use by the United States Environment Protection Agency.
New York City to Pursue Rat Contraception Pilot Program
Neutral
PRNewsWire
2 months ago
SenesTech to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
PHOENIX , Sept. 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today it will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually on Tuesday, October 1, 2024.
SenesTech to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
Neutral
PRNewsWire
3 months ago
SenesTech Announces Closing of Warrant Exercise for $2.3 Million in Gross Proceeds
PHOENIX , Aug. 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today the closing of an exercise of certain existing warrants to purchase 505,502 shares of the Company's common stock at a reduced exercise price of $4.60 per share. In addition, the Company issued new warrants, as described below.
SenesTech Announces Closing of Warrant Exercise for $2.3 Million in Gross Proceeds
Neutral
Seeking Alpha
4 months ago
SenesTech, Inc. (SNES) Q2 2024 Earnings Call Transcript
SenesTech, Inc. (NASDAQ:SNES ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Robert Blum – Lytham Partners Joel Fruendt – Chief Executive Officer Tom Chesterman – Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to the SenesTech Reports Second Quarter Fiscal Year 2024 Results. [Operator Instructions] Please note this event is being recorded.
SenesTech, Inc. (SNES) Q2 2024 Earnings Call Transcript
Neutral
PRNewsWire
4 months ago
SenesTech Announces Second Quarter 2024 Financial Results
Record Revenue and Margin Performance PHOENIX , Aug. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the second quarter of 2024. Recent Highlights Record revenues of $874,000 in the first half of 2024, an increase of 62% compared to the first half of 2023.
SenesTech Announces Second Quarter 2024 Financial Results
Charts implemented using Lightweight Charts™